Aerial shot of Cambridge Biomedical Campus

A new听economic impact report听 details the financial contributions of the Cambridge Biomedical Campus (CBC), which celebrates its 60th anniversary this autumn. 探花直播independent report by the Centre for Economics and Business Research (Cebr) for the first time calculates the economic benefits of CBC also highlights the health and research benefits for the region.

探花直播success we have on the site is not just limited to improved healthcare and treatments for patients 鈥 we generate jobs and income for businesses across Cambridge and the East of England

Kristin-Anne Rutter

探花直播key findings of the report are:

  • 探花直播campus supported an aggregate economic footprint of 拢2.2 billion worth of Gross Value Added to the UK economy and that as well as being the largest employment site in Cambridge, over 15,000 additional roles are supported across the regional supply chain and local businesses.
  • For every 10 jobs directly generated by organisations on the CBC, a further 2.7 jobs are supported within Cambridge City and South Cambridgeshire; one in every six jobs in the local authority areas are either directly or indirectly supported by the campus.
  • Employment on site is growing much faster than the rest of the UK and that 拢721m is spent by employees across the regional economy.

Looking at the wider economic picture, the research highlights that in 2021 the site reported a collaborative operating income of 拢1.9 billion, as well as contributing 拢291million to the Exchequer through tax revenues.

In addition to the new report, a series of events are planned to celebrate the success of the campus spanning 60 years and to tell more stories about the globally significant research that goes on.

Dr Kristin-Anne Rutter, Executive Director at Cambridge Biomedical Campus, said: 鈥 探花直播economic impact report for the first time demonstrates the importance of the Cambridge Biomedical Campus to the region, and to the thousands of people who work here and rely on the organisations, whether it鈥檚 as a patient or someone working on the site. 探花直播success we have on the site is not just limited to improved healthcare and treatments for patients 鈥 we generate jobs and income for businesses across Cambridge and the East of England. We do this through collaboration, with research, industry and the NHS working together to drive innovation which is then shared.

鈥 探花直播report is an important milestone, so too is our 60th anniversary and throughout September we鈥檒l be highlighting some of the amazing developments and ideas which have happened since Addenbrookes hospital and the MRC Laboratory of Molecular Biology arrived on the Hills Road site. We鈥檒l be sharing how the campus has grown and how science is taken from laboratories into hospitals, to diagnose and treat patients with world-leading innovative healthcare.鈥

Alongside the major economic impact of CBC, the research that takes place on the campus has very real and direct healthcare benefits, fuelled by innovation and discoveries that sit at the very forefront of life sciences technology and knowhow.


Life-saving treatments

Below are some of the case studies of how patients have been given, or are set to benefit from life-saving treatments, discovered and developed at CBC but with the potential to literally change the lives of people across the world.

Cytosponge: A 鈥榮ponge on a string鈥 test to detect oesophageal cancer

Around 9,100 people are diagnosed with oesophageal cancer each year in the UK. A big challenge with this type of cancer is that many people don鈥檛 realise there鈥檚 a problem until they start to have trouble swallowing. Often, these symptoms aren鈥檛 recognisable until a later stage in the disease.

But there may be an opportunity to detect the disease earlier. Some people develop a condition 鈥 called Barrett鈥檚 oesophagus 鈥 prior to developing into cancer. Barrett鈥檚 oesophagus is much more common than oesophageal cancer, and although it will only become cancer in a handful of cases, it presents an opportunity for doctors to spot a problem early and intervene before cancer develops. But the typical test for Barrett鈥檚 oesophagus, endoscopy, is both invasive and expensive.

Enter the Cytosponge.Cytosponge-TFF3 test is a 鈥榮ponge on a string鈥 device coupled with a laboratory test called TFF3 developed by scientists funded by the Medical Research Council (MRC) and Cancer Research UK 鈥 a simple, quick and affordable test for Barrett鈥檚 oesophagus that can be done in a GP surgery.

Read more

Ethanol breath biopsy clinical trial for early lung cancer detection

A new clinical trial has launched at Royal Papworth Hospital in Cambridge which is using ethanol (an alcohol) detected in exhaled breath as a potential tool to diagnose lung cancer earlier. 探花直播EVOLUTION trial is recruiting patients who definitely have lung cancer and healthy volunteers who definitely do not.
A liquid solution containing a metabolic probe is administered intravenously, travels around the body and when it reacts with a lung tumour causes the release of ethanol. After a set amount of time, patients breathe at regular intervals into a special mask which collects the ethanol which is then analysed in the laboratory. 探花直播eVOC probe (Exogenous Volatile Organic Compound) has been developed by Cambridge company Owlstone Medical, who have collaborated with Royal Papworth Hospital鈥檚 thoracic oncology research team for previous breath biopsy studies.

Changing the future of ovarian cancer

Each year, about 7,500 women in the UK are diagnosed with ovarian cancer, and around 5,000 will have the most aggressive form of the disease. 探花直播cure rate for women with ovarian cancer is very low, despite new medicines coming into the clinic. Only 43% of women in England survive five years beyond their ovarian cancer diagnosis, compared with more than 80% of people for more common cancers, such as breast (85%) and prostate (87%). This is because the disease is often diagnosed late, treatment options are limited, and many women develop resistance to current therapies. Research by Professors James Brenton and Evis Sala, at the Cancer Research UK Cambridge Centre, aims to address this.

Read more

Life-changing artificial pancreas

An artificial pancreas developed by Cambridge researchers is helping protect very young children with type 1 diabetes at a particularly vulnerable time of their lives.

探花直播artificial pancreas uses an algorithm - CamAPS FX 鈥 to determine the amount of insulin administered by a device worn by the child. It is available through a number of NHS trusts across the UK, including Cambridge 探花直播 Hospitals NHS Foundation Trust, and the team hope it will soon be available even more widely.

Read more

Adapted from a press release by Cambridge 探花直播 Health Partners



探花直播text in this work is licensed under a . Images, including our videos, are Copyright 漏 探花直播 of Cambridge and licensors/contributors as identified.听 All rights reserved. We make our image and video content available in a number of ways 鈥 as here, on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.